Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ACTRN12626000082303) titled 'Topical Dutasteride on Male pattern hairloss' on Jan. 22.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Efficacy
Primary Sponsor: Eric Song - Reskin Medical
Condition:
androgenetic alopecia
androgenetic alopecia
Skin - Dermatological conditions
Intervention:
Topical 0.025% Dutasteride solution application every 2 weeks.
Total of 3ml of solution will be applied over the entire area of hairloss, including the frontal hairline, and vertex.
The total duration of the intervention is 24 we...